EXPERIMENTAL APPROACHES TO IMMUNOPHARMACOTHERAPY FOR TOXIC HEPATITIS

EXPERIMENTAL APPROACHES TO IMMUNOPHARMACOTHERAPY FOR TOXIC HEPATITIS

Humoral and cellular factors of natural resistance in different blood vessels for experimental CCl4-hepatitis have been studied. Sharp decrease of all factors have been detected with prevailing suppression of cellular link in lever veins and gradual increase of lysozime by 14 days which supposes the...

Full description

Bibliographic Details
Main Authors:	S. Yu. Dyachkova, A. V. Turovsky
Format:	Article
Language:	Russian
Published:	Pyatigorsk Medical and Pharmaceutical Institute - branch of Volgograd State Medical University 2015-09-01
Series:	Farmaciâ i Farmakologiâ (Pâtigorsk)
Subjects:	toxic hepatitis natural immune resistance
Online Access:	https://www.pharmpharm.ru/jour/article/view/74

Similar Items

Maksar hepatoprotector is an effective corrector of prednisolone immunosuppressive action at experimental toxic hepatitis
by: A. I. Vengerovsky, et al.
Published: (2003-09-01)

Cellular Immunity State of Protein-deficient Rats with the Toxic Liver Injury
by: O.N. Voloshchuk, et al.
Published: (2017-05-01)

[Patho- and morphogenesis of microcirculation disturbances in toxic hepatitis in immature rats]
by: Rykalo N.A.
Published: (2015-09-01)

A multicenter characterization of hepatitis associated with immune checkpoint inhibitors
by: J. Randall Patrinely, et al.
Published: (2021-01-01)

Influence of methods of physical rehabilitation on quality of life in patients with toxic hepatitis
by: E.A. Shmatova, et al.
Published: (2013-11-01)

Acute Toxic Hepatitis Due To Risperidone Use: Case Report
by: Nermin Gündüz, et al.
Published: (2018-05-01)

Antioxidant activity of thiophane in rats with of experimental tetrachlorolmethane-induced hepatitis
by: V. I. Smoliyakova, et al.
Published: (2010-10-01)

HEPATOPROTECTIVE ACTION OF THYMALINUM AND SUSPENSION OF RED BONE MARROW IN TREATING EXPERIMENTAL TOXIC HEPATITIS OF RATS
by: E. F. Kulbekov, et al.
Published: (2015-09-01)

INTEGRAL ESTIMATION OF OXIDATIVE STATUS IN PATIENTS WITH ACUTE TOXIC HEPATITIS AND CHRONIC ALCOHOLIC LIVER DISEASE
by: A. Y. Shchupak, et al.
Published: (2016-03-01)

Canine hepatic slices as a model for studying drug toxicity and metabolism
by: Scott, Maya Millicent
Published: (2006)

HEPATITIS TOXICA - CASE REPORT
by: Jelena Radović, et al.
Published: (2009-04-01)

Acute Cholestatic Hepatitis Associated with Teucrium Polium
by: M Mohammadi, et al.
Published: (2007-12-01)

Hepatic toxicity of fluorene-9-bisphenol (BHPF) on CD-1 mice
by: Lei Yang, et al.
Published: (2021-08-01)

IMMUNOPATHOLOGY AND IMMUNOPHARMACOTHERAPY OF CORONAVIRUS DISEASE 2019 (COVID-19): FOCUS ON INTERLEUKIN 6
by: E. L. Nasonov
Published: (2020-06-01)

Markers of progression of liver fibrotic changes in patients with chronic toxic drug-induced hepatitis
by: V.I. Didenko, et al.
Published: (2021-06-01)

Cholestatic hepatitis with ciprofloxacin therapy: A Case Report
by: A. R. M. Misthaq, et al.
Published: (2019-10-01)

Incidence and risk of hepatic toxicities with PD-1 inhibitors in cancer patients: a meta-analysis
by: Zhang X, et al.
Published: (2016-09-01)

HEPATOPROTECTIVE EFFECT OF LECITHIN-BASED PREPARATION ON EXPERIMENTAL ANIMAL LIVER TOXICITY
by: Ye. V. Kuzminova, et al.
Published: (2018-05-01)

Acylcarnitine Profiles in Acetaminophen Toxicity in the Mouse: Comparison to Toxicity, Metabolism and Hepatocyte Regeneration
by: Jack Hinson, et al.
Published: (2013-08-01)

THE USE OF INDIVIDUAL LIPID FRACTIONS SAPROPEL FOR CORRECTION OF THE LIVER EXCRETORY FUNCTIONS OF RATS WITH TOXIC CHEMICAL HEPATITIS
by: S. V. Nizkodubovа, et al.
Published: (2014-12-01)

Algunas consideraciones clinicopatogénicas de las hepatitis tóxicas Some clinical pathogenetic considerations on toxic hepatopathies
by: Tania Delia Carbonell Amiot, et al.
Published: (2012-01-01)

Aplastic Anemia and Severe Myelosuppression with Boceprevir or Simeprevir-Containing Hepatitis C Virus Treatment
by: Alicia Senín, et al.
Published: (2017-03-01)

Selenium-enriched Bifidobacterium longum DD98 attenuates irinotecan-induced intestinal and hepatic toxicity in vitro and in vivo
by: Hui Zhu, et al.
Published: (2021-11-01)

The characteristics of immune status and carbohydrate metabolism at different stages of liver fibrosis in patients with hepatitis C virus-related chronic hepatitis
by: Yu.M. Stepanov, et al.
Published: (2020-02-01)

Idiosyncratic hepatic toxicity in autosomal dominant polycystic kidney disease (ADPKD) patient in combined treatment with tolvaptan and amoxicillin/clavulanic acid: a case report
by: Angela Maria Pellegrino, et al.
Published: (2019-11-01)

The antidysbiotic and antiphlogistic actions of quertulin at the experimental toxic hepatitis
by: A. P. Levitsky, et al.
Published: (2017-03-01)

Effect of CyberKnife stereotactic body radiation therapy for hepatocellular carcinoma on hepatic toxicity
by: Liang P, et al.
Published: (2016-11-01)

Acute and fulminant hepatitis induced by flutamide: Case series report and review of the literature
by: Brahm Javier, et al.
Published: (2011-01-01)

Severe toxic acute liver injury
by: Mitrović Nikola, et al.
Published: (2019-01-01)

Fulminant hepatitis during self-medication with conjugated linoleic acid
by: Rita Nortadas, et al.
Published: (2012-03-01)

Management of Dermatologic Toxicities Related to Immune Checkpoint Inhibitors
by: Xiaoyan SI, et al.
Published: (2019-10-01)

The research of hepatoprotective activity in experimental hepatitis influenced by 1,2,4-triazole derivatives
by: I. M. Bilay, et al.
Published: (2014-08-01)

Morphological changes in kidney glomeruli of rats with chronic toxic hepatitis and its correction with lisinopril, L-arginine-L-glutamate and their combination
by: N. A. Rykalo, et al.
Published: (2019-05-01)

Study of Impacts of Ganoderma applanatum (Pres.) Pat. Extract on Hepatic and Renal Biochemical Parameters of Rats
by: Sukumar Dandapat, et al.
Published: (2019-07-01)

Morphological changes in the broiler chickens liver at use of “Karsilin” in conditions of infectious-toxic hepatitis modelling
by: T. I. Fotina, et al.
Published: (2018-11-01)

Managing toxicities associated with immune checkpoint inhibitors: consensus recommendations from the Society for Immunotherapy of Cancer (SITC) Toxicity Management Working Group
by: I. Puzanov, et al.
Published: (2017-11-01)

Phenotypic profile and factors of blood lymphocytes apoptosis induction in patients having diffuse toxic goiter
by: O. I. Ourazova, et al.
Published: (2007-03-01)

Gallbladder Hydrops Associated with an Episode of Acute Liver Toxicity in the Adult: May It Be Considered a Surgical Emergency or Not?
by: Albu Sorin, et al.
Published: (2016-09-01)

Evaluation of response to hepatitis B virus vaccine in adults with human immunodeficiency virus
by: Arlete F. Rech-Medeiros, et al.
Published: (2019-09-01)

Interferon therapy shifts natural killer subsets among egyptian patients with chronic hepatitis C
by: Amal Fathy, et al.

Cannot write session to /tmp/vufind_sessions/sess_um5dnca3bt5lrh8vtaus34j4eq